Reversible craniocervical dystonia associated with levofloxacin

Journal of Clinical Movement Disorders
Karlo J LizarragaCarlos Singer

Abstract

Dystonia is a hyperkinetic movement disorder related to dysfunction of inhibitory basal ganglia and cortical circuits. GABA is the major inhibitory neurotransmitter in the central nervous system. Quinolones can rarely produce serious neurologic effects, which have been attributed to impaired inhibition through GABA antagonism. We report a case of reversible craniocervical dystonia associated with oral levofloxacin. A 62-year-old man on hemodialysis presented with craniocervical dystonia 3 days after initiation of levofloxacin 500 mg. twice daily. Levofloxacin was discontinued. Seven days later the abnormal movements completely disappeared and did not recur in the following 3 months. Levofloxacin should be considered as a rare but potentially reversible trigger of craniocervical dystonia. Older age, renal impairment and high doses of the drug might be risk factors.

References

Oct 1, 1990·The Journal of Antimicrobial Chemotherapy·W Christ
Jul 1, 1990·British Journal of Clinical Pharmacology·E UnseldU Klotz
Feb 1, 1990·DICP : the Annals of Pharmacotherapy·M T Schwartz, J F Calvert
Jan 1, 1984·European Neurology·D HípolaS Giménez-Roldán
Jan 1, 1995·General Hospital Psychiatry·J FarringtonJ Tierney
Feb 1, 1996·The Annals of Pharmacotherapy·R J Thomas, D R Reagan
Feb 1, 1997·Clinical Pharmacokinetics·D N Fish, A T Chow
Sep 23, 1998·American Journal of Ophthalmology·A Castelbuono, N R Miller
Dec 20, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P BallG Tillotson
Aug 6, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kevin M SowinskiRichard J Hamburger
May 11, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Bart PostMarina A J Tijssen
Mar 2, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Susan AzarJay A Van Gerpen
Mar 16, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Yuk-Fai CheungPatrick Chung-Ki Li
May 22, 2009·Parkinsonism & Related Disorders·Mark S LeDoux
Feb 18, 2010·Indian Journal of Medical Sciences·Dinesh Dutt SharmaRamesh Kumar
Jul 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Stefania Lalli, Alberto Albanese
May 8, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Alberto AlbaneseJan K Teller

❮ Previous
Next ❯

Citations

Sep 16, 2016·Mediators of Inflammation·Drenka TrivanovićAleksandra Jauković
Sep 27, 2018·Hemodialysis International·Najia IdreesBertrand L Jaber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.